Attached files

file filename
EX-99.2 - EX-99.2 - MEDIVATION, INC.d208883dex992.htm
EX-99.1 - EX-99.1 - MEDIVATION, INC.d208883dex991.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 23, 2016

 

 

MEDIVATION, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-32836   13-3863260

(State or other jurisdiction

of incorporation)

 

(Commission

File No.)

 

(IRS Employer

Identification No.)

525 Market Street, 36th Floor

San Francisco, California 94105

(Address of principal executive offices and zip code)

Registrant’s telephone number, including area code: (415) 543-3470

 

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

x Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 8.01 Other Events.

On June 23, 2016, Medivation, Inc. (the “Company”) issued a press release announcing that the Company had mailed a letter to Company stockholders providing detailed information to correct misleading claims that Sanofi has made (the “Stockholder Letter”). A copy of the press release, including the Stockholder Letter, is attached hereto as Exhibit 99.1.

On June 23, 2016, the Company sent a letter to its employees addressing the Stockholder Letter. A copy of the letter to the Company’s employees is attached hereto as Exhibit 99.2.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

99.1    Press release of Medivation, Inc. dated June 23, 2016.
99.2    Letter to Medivation employees sent on June 23, 2016.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  MEDIVATION, INC.
Dated: June 23, 2016   By:  

/s/ Andrew Powell

    Andrew Powell
    General Counsel


EXHIBIT INDEX

 

99.1    Press release of Medivation, Inc. dated June 23, 2016.
99.2    Letter to Medivation employees sent on June 23, 2016.